NEW DELHI: The US Food and drug administration(USFDA) has approved JB Chemicals & Pharmaceuticals' (JBCPL) abbreviated new drug application (ANDA) for 25 mg and 50 mg delayed release tablets of Diclofenac Sodium (non-steroidal anti-inflammatory drug).
No comments:
Post a Comment